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background: Dual antiplatelet therapy (DAPT) compared to single antiplatelet therapy in patients with prior stroke was reported to be associated 
with prohibitively higher risk for intracranial bleeding. In the
real clinical practice, however, long-term DAPT is widely used in patients with prior stroke undergoing percutaneous coronary intervention (PCI).
methods: The CREDO-Kyoto (Coronary REvascularization Demonstrating Outcome study in Kyoto) registry cohort-2 is a multi-center registry 
enrolling consecutive patients undergoing first coronary revascularization between 2005 and 2007. We compared 5-year clinical outcome after 
PCI between the 2 groups of patients with (N=1,384) or without prior stroke (N=11,674). We also assessed the influence of prolonged DAPT on 
clinical outcomes with landmark analysis at 13 months after PCI in patients with prior stroke. results: Prior stroke was independently associated 
with higher risk for all-cause death and stroke (adjusted hazard ratio [HR] 1.37, 95% confidence interval [CI] 1.23-1.52; P<0.0001 and HR 2.03, 
95% CI 1.71-2.41; P<0.0001, respectively), but not for myocardial infarction (MI) (HR 1.10, 95% CI 0.86-1.40; P=0.43). In the 13-month landmark 
analysis, prolonged DAPT in patients with prior stroke was not associated with lower risk for all-cause death and recurrent stroke (HR 0.79, 95% 
CI 0.6-1.05; P=0.1, and HR 1.07, 95% CI 0.7-1.66; P=0.76, respectively). Cumulative incidences of MI and hemorrhagic stroke beyond 13-month 
were not significantly different between on-DAPT and off-DAPT groups (3.0% versus 3.6%, P=0.9, and 2.6% versus 1.9%, P=0.7) conclusions: Prior 
history of stroke was associated with higher risk for all-cause death and stroke, but not for MI. Prolonged use of DAPT was not associated with better 
cardiovascular outcome including recurrent stroke.
